Whanin Pharm Long-term Investment Intensity
Whanin Pharm long-term investment intensity. Whanin Pharm (016580) has a Long-term Investment Intensity of 7.0% as of December 2019. Long-term investments of ₩21.21 Billion represent 7.0% of total assets of ₩304.88 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 016580 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Whanin Pharm (2009–2019)
Long-term investment intensity of Whanin Pharm from 2009 to 2019. This chart shows how Whanin Pharm's Long-term Investment Intensity has evolved across 5 annual periods from 2009 to 2019. As of December 2019, the intensity stands at 7.0%, reflecting long-term investments of ₩21.21 Billion against total assets of ₩304.88 Billion KRW. See Whanin Pharm (016580) defensive interval to measure how many days the company can operate on defensive assets alone.
Whanin Pharm Long-term Investment Intensity by Year (2009–2019)
Whanin Pharm long-term investment intensity by year from 2009 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Whanin Pharm from 2009 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Whanin Pharm.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 7.0% | ₩21.21 Billion | ₩304.88 Billion | ▼ -0.6 pp |
| 2018 | 7.5% | ₩21.67 Billion | ₩287.69 Billion | ▲ +4.8 pp |
| 2012 | 2.8% | ₩5.00 Billion | ₩181.43 Billion | ▼ -0.3 pp |
| 2011 | 3.0% | ₩5.01 Billion | ₩166.11 Billion | ▲ +0.8 pp |
| 2009 | 2.2% | ₩2.59 Billion | ₩118.95 Billion | — |